Search clinical trials for: Oxaliplatin (OXAL)

Total 9937 results

Eli Lilly and Company

Completed

A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma

Advanced Gastric Carcinoma

Italy
Salah Azaïz Cancer Institute

Active, not recruiting

Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer

Rectal Cancer | Locally Advanced

Tunisia
Zhiyong Huang

Not yet recruiting

Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma

China
Sun Yat-sen University

Active, not recruiting

Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Advanced Rectal Cancer

China
Peking University

Completed

A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric Cancer

Gastric Cancer

China
National University Hospital, Singapore
Yonsei University; National Cancer Centre, Singapore

Unknown

A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients (3G)

Recurrent Gastric Cancer

Singapore
Zhu Xu

Unknown

Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases

Colon Cancer Liver Metastasis

China
Spanish Cooperative Group for the Treatment of...
Sanofi; Hoffmann-La Roche

Completed

Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General Status

Gastric Cancer

Spain
National Cancer Institute (NCI)

Terminated

Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
The University of Hong Kong

Unknown

Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma (SECOX)

Advanced Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma

China
Dorte Nielsen

Completed

Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma

Cholangiocarcinoma

Denmark
Centre Hospitalier Universitaire de Besancon
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer (EROS)

Metastatic Colorectal Cancer

France
Asan Medical Center

Completed

Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin

Advanced Gastric Cancer

Korea, Republic of
Charite University, Berlin, Germany

Completed

FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer (PaFLO)

Advanced Gastric Cancer

Germany
UNC Lineberger Comprehensive Cancer Center
Bristol-Myers Squibb; National Cancer Institute (NCI); Sanofi; Roche Pharma AG; National...

Completed

Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer (NRR)

Liver Cancer

United States
Zhu Xu

Unknown

Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE

Advanced Adult Primary Liver Cancer

China
NSABP Foundation Inc
National Cancer Institute (NCI)

Terminated

Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer

Colorectal Cancer | Metastatic Cancer

United States
National Cancer Institute (NCI)

Terminated

Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Vejle Hospital

Completed

Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma

Cholangiocarcinoma

Denmark
Rabin Medical Center

Unknown

Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM.

Liver Metastasis Colon Cancer

Israel
Asan Medical Center

Completed

Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer

Stomach Cancer

Korea, Republic of
Liangjun Zhu M.M.
Zhangjiagang First People's Hospital

Recruiting

Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma

Metastatic or Recurrent Gastric Adenocarcinoma

China
Tianjin Medical University Cancer Institute and...

Recruiting

Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer

Gastric Cancer | Perioperative | Sintilimab

China
M.D. Anderson Cancer Center

Completed

Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon Carcinoma

Colorectal Cancer

United States
Cancer Institute and Hospital, Chinese Academy...

Unknown

SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer

Gastric Cancer

China
The Nordic Colorectal Cancer Biomodulation Group

Completed

FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer

Metastatic Colorectal Cancer

Norway
Fujian Cancer Hospital

Recruiting

Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer

Immunotherapy | Gastrict Cancer

China
Seoul St. Mary's Hospital

Recruiting

Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis (IPXELOX)

Stomach Neoplasms | Peritoneal Metastases | Paclitaxel

Korea, Republic of
Dong Wang

Not yet recruiting

Paclitaxel (Albumin-bound) and Oxaliplatin for Advanced Hepatobiliary and Malignant Tumors

Advanced Hepatobiliary and Malignant Tumors
Kangbuk Samsung Hospital

Terminated

S-1/Oxaliplatin for High Risk Patients Who Underwent Gastrectomy (SOHUG)

Stomach Cancer

Korea, Republic of
First Affiliated Hospital of Zhejiang University

Unknown

mXELOXIRI Combined With Molecular Targeted Drug in mCRC (TRICAP)

Unresectable Metastatic Colorectal Cancer

China
University of Chicago
National Cancer Institute (NCI)

Completed

Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Colorectal Cancer

United States
Hallym University Medical Center
Sanofi; Asan Medical Center

Completed

Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer

Stomach Neoplasms

Korea, Republic of
Sun Yat-sen University
Taiho Pharmaceutical Co., Ltd.

Completed

S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients

Gastric Cancer

China
Shanghai Junshi Bioscience Co., Ltd.

Not yet recruiting

Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study

Intrahepatic Cholangiocarcinoma

China
National Cancer Institute (NCI)

Recruiting

A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)

Bile Duct Cancer | Biliary Cancer | Cancer of the Bile Duct

United States
Tianjin Medical University Cancer Institute and...

Not yet recruiting

XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma

Gastric Carcinoma
Lund University Hospital

Completed

Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol. (PALAESTRA)

Adenocarcinoma of the Esophagus or Esophagogastric Junction

Sweden
Asan Medical Center

Completed

RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOX

Advanced Gastric Cancer

Korea, Republic of
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Sanofi; Pfizer

Completed

Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer

Recurrent Small Intestine Cancer | Small Intestine Adenocarcinoma

United States
Roswell Park Cancer Institute

Terminated

Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer

Colorectal Cancer

United States
Shanghai Zhongshan Hospital

Not yet recruiting

Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Gastric Cancer

China
Michael Bau Mortensen

Recruiting

Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients

Colo-rectal Cancer | Peritoneal Carcinomatosis | Peritoneal Metastases | Peritoneum Cancer

Denmark
Baylor College of Medicine

Completed

Corticosteroids in Postoperative Critically Ill Neonates With Low Cardiac Output Syndrome With Congenital Heart Disease (Corti)

Cardiac Output, Low

United States
Cancer Institute and Hospital, Chinese Academy...

Completed

The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer

Stomach Neoplasms

China
Xu jianmin
Ruijin Hospital; Zhejiang University; The Second Affiliated Hospital of Harbin...

Unknown

A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer

Colorectal Cancer | Metastasis

China
Mayo Clinic

Completed

Stage IV Colorectal CA ALIMTA

Locally Advanced Unresectable or Stage IV Colorectal Cancer

United States
Harbin Medical University

Not yet recruiting

Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab

Rectal Cancer
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Camrelizumab Combined With Chemotherapy and Radiotherapy Perioperative Treatment of Esophageal Gastric Junction Adenocarcinoma

Gastroesophageal Junction Adenocarcinoma (Siewert II-III)

China
池畔

Not yet recruiting

Organ Preservation Following Enverolimab-based Total Neoadjuvant Therapy for Locally Advanced Very Low Rectal Cancer (TRACE-LE)

Rectal Cancer

China

3

Subscribe